Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis

Abstract Background & Aims Ticagrelor has been acknowledged as a new oral antagonist of P2Y12-adenosine diphosphate receptor, as a strategy with more rapid onset as well as more significant platelet inhibition function in acute coronary syndrome (ACS) patients. The clinical benefit of ticagrelor...

Full description

Bibliographic Details
Main Authors: Dong Wang, Xiao-Hong Yang, Ji-Dong Zhang, Rui-Bin Li, Min Jia, Xiao-Ran Cui
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Cardiovascular Disorders
Subjects:
Ticagrelor
Clopidogrel
Acute coronary syndrome
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12872-018-0948-4

Internet

http://link.springer.com/article/10.1186/s12872-018-0948-4

Similar Items